Variations in Use of Diabetes Drugs With Cardiovascular Benefits Among Medicaid Patients
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.40117
Abstract: This cross-sectional study evaluates the variations in use of diabetes drugs with cardiovascular benefits among Medicaid patients. read more here.
Keywords: diabetes drugs; variations use; use diabetes; benefits among ... See more keywords
Cardiovascular benefits of GLP-1RA and SGLT-2i in women with type 2 diabetes.
Sign Up to like & getrecommendations! Published in 2022 at "Primary care diabetes"
DOI: 10.1016/j.pcd.2022.03.012
Abstract: Given the CV benefit noted in the CVOTs, GLP-1RAs and SGLT-2is are given preference in T2DM guidelines. While guidelines do not report potential gender difference, those differences exist. On restricting the CVOTs results to women… read more here.
Keywords: diabetes cardiovascular; sglt women; glp 1ra; 1ra sglt ... See more keywords
Cardiovascular benefits and risks of testosterone replacement: another warning?
Sign Up to like & getrecommendations! Published in 2017 at "Cardiovascular Research"
DOI: 10.1093/cvr/cvx143
Abstract: Although testosterone (T) replacement is increasingly being used clinically, cardiovascular benefits and risks of T administration to older men with age-related decline in T levels remain uncertain. The WHI randomized trial reporting potential harmful coronary… read more here.
Keywords: risks testosterone; replacement another; testosterone replacement; cardiovascular benefits ... See more keywords
A review of cardiovascular benefits of SGLT2 inhibitors.
Sign Up to like & getrecommendations! Published in 2022 at "Medicine"
DOI: 10.1097/md.0000000000030310
Abstract: Sodium-glucose cotransporter 2 inhibitor (SGLT2I) is a new type of hypoglycemic drug that targets the kidney. As research continues to advance on this topic, it has been found that SGLT2I has multiple protective effects, such… read more here.
Keywords: sglt2 inhibitors; review cardiovascular; cardiovascular benefits; benefits sglt2 ... See more keywords
Cardiovascular Benefits of Extended-Time Nocturnal Hemodialysis.
Sign Up to like & getrecommendations! Published in 2020 at "Current vascular pharmacology"
DOI: 10.2174/1570161118666200401112106
Abstract: Hemodialysis (HD) remains the most utilized treatment for End Stage Kidney Disease (ESKD) globally, mainly as conventional HD administered in 4 h sessions thrice weekly. Despite advances in HD delivery, patients with ESKD carry a… read more here.
Keywords: hemodialysis; time; physiology; benefits extended ... See more keywords
Cardiovascular Benefits from Gliflozins: Effects on Endothelial Function
Sign Up to like & getrecommendations! Published in 2021 at "Biomedicines"
DOI: 10.3390/biomedicines9101356
Abstract: Type 2 diabetes mellitus (T2DM) is a known independent risk factor for atherosclerotic cardiovascular disease (CVD) and solid epidemiological evidence points to heart failure (HF) as one of the most common complications of diabetes. For… read more here.
Keywords: effects endothelial; endothelial function; gliflozins effects; benefits gliflozins ... See more keywords
Sympatholytic Mechanisms for the Beneficial Cardiovascular Effects of SGLT2 Inhibitors: A Research Hypothesis for Dapagliflozin’s Effects in the Adrenal Gland
Sign Up to like & getrecommendations! Published in 2021 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms22147684
Abstract: Heart failure (HF) remains the leading cause of morbidity and death in the western world, and new therapeutic modalities are urgently needed to improve the lifespan and quality of life of HF patients. The sodium-glucose… read more here.
Keywords: sglt2 inhibitors; blood glucose; sympatholytic effects; hypothesis ... See more keywords